BETHLEHEM, Pa.--(BUSINESS WIRE)--Saladax Biomedical, developer of the Personalized Chemotherapy Management (PCM®) line of tests to measure blood levels of cancer drugs, was pleased to accept the Product Innovation Award from the Ben Franklin Technology Partners of Northeastern Pennsylvania at the i xchange awards ceremony May 12th.
